# Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CT

> **NCT02798562** · NA · UNKNOWN · sponsor: **RWTH Aachen University** · enrollment: 400 (estimated)

## Conditions studied

- BI-RADS 4
- BI-RADS 5
- BI-RADS 6
- High Risk of Breast Cancer Which Indicates a Mamma-MRI

## Interventions

- **DEVICE:** Native and dynamic contrast-enhanced CT

## Key facts

- **NCT ID:** NCT02798562
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798562, "Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CT". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02798562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*